Gene Query: OGFOD2

Dataset Description Geneva Score
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 11.88
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 11.84
Patient-derived luminal breast cancer xenografts with progestins 8.72
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 8.72
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 8.33
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 6.76
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 5.48
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 5.4
SRSF2 mutations impair hematopoiesis and alter exon recognition 5.27
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 5.08
Identification of transcription start sites for human A549 cell line using ReCappable-seq 4.87
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 4.61
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 4.6
The Human Testis Cell Atlas via Single-cell RNA-seq 4.51
RNA-seq of tumor cells following angiopellosis extravasation 4.33
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 4.22
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 4.1
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 4.09
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 3.99
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 3.88
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 3.78
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 3.64
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 3.52
U1 snRNP telescripting regulates size-function stratified human genome 3.48
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 3.46
ENCODE Cold Spring Harbor Labs Long RNA-seq 3.22
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 3.21
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 3.21
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 3.2
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 3.2
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 3.19
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 3.17
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 3.16
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 3.16
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 3.14
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 2.98
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 2.94
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 2.9
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 2.85
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 2.85
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 2.75
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 2.74
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 2.72
Differentially expressed genes post knock down of lincDUSP26 2.68
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 2.65
NR2F2 study 2.61
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 2.61
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 2.57
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 2.55
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 2.55
SLAM-seq for K562 endogenous mRNA decay 2.55
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 2.48
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 2.46
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 2.44
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 2.44
Silencing p300 in MCF7 cells to study expression and alternative splicing 2.43
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 2.41
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 2.39
Characterization of human ILC2 subsets 2.38
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 2.37
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 2.35
RNA polymerase in pre-B-ALL cell lines 2.28
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 2.28
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 2.27
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 2.27
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 2.27
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 2.26
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 2.22
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 2.21
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 2.18
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 2.18
Accurate annotation of human protein-coding small open reading frames 2.17
CUREfast: Accelerating research with families 2.14
Impact of dieldrin on transcription in Jurkat T cells 2.08
Genome-wide discovery of human splicing branchpoints [RNAse] 2.05
DRB/GRO-Seq -/+ UV 2.01
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 1.99
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 1.96
In situ CAPTURE of chromatin interactions by biotinylated dCas9 1.96
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 1.95
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 1.94
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 1.93
Mutational landscape of splicing genes and functional consequences across 33 cancer types 1.92
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 1.87
Transcriptome-wide identification of CELF2 functional targets in T cells 1.87
Gene expression in GBM with Cav3.2 inhibition 1.86
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.85
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 1.84
RNA-Seq and expression data from human adipose tissue 1.84
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 1.84
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 1.83
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 1.81
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 1.8
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 1.8
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.79
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 1.79
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 1.79
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 1.78
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 1.78
Paxillin regulates genomic networks in prostate cancer [PC3] 1.77
Gene Expression Profiling of WT and KDM3A Knocked out Cell 1.76
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 1.76
Targeted enhancer activation by a subunit of the integrator complex 1.76
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 1.73
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 1.73
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 1.72
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 1.71
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 1.71
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 1.69
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 1.69
mRNA expression profile of Lymphocytes by high-throuput sequencing 1.67
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 1.67
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 1.66
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 1.65
Dysregulated immune system networks in war veterans with PTSD 1.64
Discovering human diabetes-risk gene function with genetics and physiological assays 1.64
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 1.63
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 1.63
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 1.63
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 1.63
H1609088 Human RNA-Sequencing 1.62
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 1.59
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 1.58
Modulation of nonsense-mediated decay by rapamycin 1.58
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 1.56
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 1.56
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 1.56
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 1.55
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 1.55
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 1.54
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 1.53
The evolution of N6-methyladenosine in primates 1.52
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 1.51
Analysis of transcriptional regulation by Myt1 and Myt1l 1.51
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 1.5
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 1.49
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 1.49
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 1.48
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 1.48
Chromatin-informed inference of transcriptional programs in gynecologic cancers 1.48
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 1.48
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 1.47
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 1.47
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 1.47
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 1.47
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.46
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 1.46
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 1.45
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 1.45
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 1.44
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 1.43
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 1.42
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 1.41
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 1.41
Bone marrow derived human B cells [normal proB] 1.4
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 1.39
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 1.39
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 1.39
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 1.39
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 1.38
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 1.38
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 1.38
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 1.38
RIG-I and MDA5 fRIP during KSHV lytic reactivation 1.37
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 1.37
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 1.37
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 1.36
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 1.36
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 1.35
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 1.35
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 1.35
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 1.34
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 1.34
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 1.34
Glioblastoma stem cells infected by ZIKA virus 1.33
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 1.33
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 1.33
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 1.33
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 1.33
TT-Seq captures the human transient transcriptome 1.33
Global analysis of enhancer targets: Mosaic-seq 1.32
Transciptomic profiling of human fetal lung samples 1.32
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 1.32
METTL3 promotes translation in human cancer cells 1.31
Gene Expression Profiling of SPOP Knocked Down Cell 1.3
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 1.3
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 1.3
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 1.3
Primary Human B-cell Temporal Response to CD40L Stimulation 1.28
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 1.27
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 1.27
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 1.27
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 1.27
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 1.26
Spliceosomal disruption of the non-canonical BAF complex in cancer 1.25
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 1.25
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 1.25
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 1.23
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 1.22
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 1.21
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 1.2
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 1.2
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 1.2
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 1.2
Overexpression of NFIB and YBX1 in MCF-7 cells 1.19
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 1.19
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 1.18
Small-molecule targeting of brachyury transcription factor addiction in chordoma 1.17
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 1.17
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 1.16
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 1.16
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 1.15
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 1.15
PRDM1 inhibits proliferation of human colon cancer organoids 1.15
Differential gene expression of human melanoma cells [RNA-seq] 1.15
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 1.15
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 1.15
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 1.15
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 1.14
LIN28A Over-expression RNAseq 1.13
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 1.12
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 1.12
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 1.12
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 1.11
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 1.11
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 1.11
A Unique Epigenomic Landscape Defines Human Erythropoiesis 1.09
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 1.09
Regulation of poly(A) tail and translation during the somatic cell cycle 1.09
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 1.09
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 1.08
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 1.08
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 1.08
RNA-Seq with and without RNase treatment in PCa cell lines 1.07
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 1.06
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 1.06
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 1.06
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 1.06
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 1.06
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 1.06
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 1.05
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 1.05
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 1.05
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 1.05
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 1.04
HEXIM1 is induced by DHODH inhibition to suppress melanoma 1.04
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 1.04
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 1.04
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 1.03
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 1.03
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 1.02
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 1.02
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 1.02
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.01
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 1.01
U2AF1 mutations alter splice site recognition in hematological malignancies 1.01
UV_24h_GRO-Seq 1.01
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 1.0
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.0
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 1.0
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 0.99
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 0.98
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 0.97
Genome-wide discovery of human splicing branchpoints 0.96
AUF-1 affected genes in human skin cells 0.95
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 0.94
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 0.93
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 0.93
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 0.93
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 0.92
RNA-seq analysis of differentiating human erythroblasts 0.91
RNA-seq of Single-Cell Genotyping of Transcriptomes 0.9
Single-Cell Genotyping of Transcriptomes 0.9
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 0.89
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 0.89
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.89
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.89
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 0.87
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.87
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.87
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 0.86
Stem and effector CD8 T-cells from human cancers 0.86
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 0.86
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 0.85
Illumina Total RNA-seq in HeLa 0.84
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.84
Gene expression analysis upon mtDNA depletion 0.84
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 0.84
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 0.82
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 0.82
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.82
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.81
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 0.81
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 0.81
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 0.81
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 0.8
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.79
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 0.78
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 0.78
RNA-seq of resting and activated CD4+ T cells +-JQ1 0.78
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.77
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 0.76
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 0.76
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 0.76
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 0.75
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.75
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.75
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.73
quanTIseq: quantifying immune contexture of human tumors 0.73
CD86 regulates a pro-survival signal in myeloma cells 0.71
Comprehensive comparative analysis of 5’ end RNA sequencing methods 0.71
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 0.71
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.7
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 0.68
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 0.68
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 0.68
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 0.68
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 0.66
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 0.66
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 0.65
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 0.64
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 0.64
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 0.64
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 0.64
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 0.63
High-throughput sequencing of pluripotent cells 0.62
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.62
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 0.62
Iron response of HepG2 cells 0.61
mRNA recovered upon RNF219 IP. [RNA-IP] 0.6
Functional significance of the HIV-1 Tat signature amino acid residues 0.59
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 0.59
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 0.58
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 0.58
Identification of long noncoding RNAs in T-ALL cell lines 0.58
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 0.58
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.57
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.57
K562 polyA RNA-Seq 0.57
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.57
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 0.56
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 0.56
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 0.56
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.56
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 0.55
Analyses of T-ALL (COG study) 0.55
RNA sequencing of T-ALL (COG study) 0.55
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.54
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 0.53
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 0.53
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 0.53
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 0.53
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.52
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.52
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.52
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 0.51
Interaction between mitoNEET and NAF-1 in cancer cells 0.51
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 0.5
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 0.5
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.5
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.48
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 0.48
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.47
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 0.47
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 0.46
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 0.46
Gene expression profiling of leukemia cells following asparagine depletion 0.45
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.45
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.45
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 0.44
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.44
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.43
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 0.43
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 0.43
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 0.43
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 0.42
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 0.42
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 0.42
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.42
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.42
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 0.42
Regulating Interleukin-2 activity with engineered receptor signaling clamps 0.41
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 0.4
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 0.4
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.39
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.39
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.38
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 0.37
Gene expression analysis of breast cancer cell-lines 0.36
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.36
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 0.36
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.36
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.36
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 0.36
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 0.35
The transcriptome effect of overexpressing EZH2 in MCF7 0.34
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 0.34
Molecular analysis of renal cell carcinoma with unclassfied histology 0.34
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.34
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 0.34
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 0.34
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.34
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.34
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.33
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.33
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 0.32
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.32
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 0.32
RNA editing in nascent RNA affects pre-mRNA splicing 0.32
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.32
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 0.31
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 0.3
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 0.3
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.3
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.29
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.29
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.27
Silencing SPIB in attached and floating state of H1703 lung cancer cells 0.26
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.26
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 0.26
Preclinical model of obesity and ER-positive breast cancer 0.26
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.26
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.26
Specific molecular signatures underlie response to decitabine in CMML 0.26
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.26
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.26
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.26
BACH2 in human plasma cell fate decision 0.26
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.25
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.24
Energy Metabolism during Anchorage-Independence 0.24
RNA-seq differential expression studies: more sequence, or more replication? 0.23
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 0.23
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 0.23
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 0.23
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 0.22
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.21
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 0.21
miRNAs affected by antagomiR-17 treatment 0.2
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.19
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.19
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 0.19
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.19
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.17
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.16
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 0.16
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.16
Transcriptome analysis of SKI knock-out in HL60 cells 0.15
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 0.15
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 0.15
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.15
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.15
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.14
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.14
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 0.14
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 0.14
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 0.14
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.14
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.13
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.13
Oncogenic roles of ARID5B in T-ALL 0.13
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.12
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 0.12
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 0.12
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.12
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 0.12
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 0.11
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 0.11
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.11
Investigate A2M treatment on human prostate cancer xenograft in mice 0.11
Investigate A2M treatment on human prostate cancer and mouse liver 0.11
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 0.11
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.1
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.1
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.1
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.1
ARS2 is a general suppressor of pervasive transcription [RNAseq] 0.1
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 0.09
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.09
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.09
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.07
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.07
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 0.07
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 0.06
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.05
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 0.05
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 0.04
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 0.04
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.04
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 0.04
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.03
Leucegene: AML sequencing (part 6) 0.03
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.03
RNAseq of cell lines with knocked in ESR1 mutations 0.02
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.02
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.02
RNA-Seq from human ILC transitional populations 0.01
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 0.01
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 0.01
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation